πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 204 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9988603

Large scale generation of functional megakaryocytes and platelets from human embryonic ste

Stem Cell & Regenerative Medicine International Β· Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9896502

Antagonist antibodies directed against calcitonin gene-related peptide and methods using s

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9890211

Antagonist antibodies directed against calcitonin gene-related peptide

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9890210

Antagonist antibodies directed against calcitonin gene-related peptide

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9884907

Methods for treating headache using antagonist antibodies directed against calcitonin gene

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9884908

Methods for treating headache using antagonist antibodies directed against calcitonin gene

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9814706

Hydrobromide salt of pridopidine

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9796673

L-tartrate salt of pridopidine

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9789057

Pharmaceutical delivery system

Perrigo Pharma International Designated Activity Company Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9763904

Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9737560

Process for preparation of a humic substance based gel for targeted external application

BlackBalm, LLC Β· Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9730972

Skin tightening lotion

Ashley Diana Black International Holdings, LLC Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9708610

Compositions comprising alternating 2β€²-modified nucleosides for use in gene modulation

Ionis Pharmaceuticals, Inc. Β· Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9707270

Method for administering Ο‰-conopeptide

Jazz Pharmaceuticals International III Limited Β· Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9687441

Compositions for use with a fascia tissue treatment device to reduce cellulite

Ashley Diana Black International Holdings, LLC Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9682033

Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9649291

Treatment for obesity

Jazz Pharmaceuticals International III Limited Β· Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9593162

Internalizing human monoclonal antibodies targeting prostate cancer cells in situ

The Regents of the University of California Β· Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9592291

Methods for iontophoretically treating nausea and migraine

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9585863

Treatment of cataplexy

Jazz Pharmaceuticals International III Limited Β· Granted Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9567402

Internalizing human monoclonal antibodies targeting prostate and other cancer cells

The Regents of the University of California Β· Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9427578

Pharmacokinetics of iontophoretic sumatriptan administration

TEVA PHARMACEUTICALS INTERNATIONAL GMBH Β· Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9388244

Internalizing ErbB2 antibodies

The Regents of the University of California Β· Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9359418

Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted